Year |
Citation |
Score |
2012 |
Haddach M, Michaux J, Schwaebe MK, Pierre F, O'Brien SE, Borsan C, Tran J, Raffaele N, Ravula S, Drygin D, Siddiqui-Jain A, Darjania L, Stansfield R, Proffitt C, Macalino D, et al. Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor. Acs Medicinal Chemistry Letters. 3: 135-9. PMID 24900437 DOI: 10.1021/ml200259q |
0.333 |
|
2010 |
Sellers RP, Alexander LD, Johnson VA, Lin CC, Savage J, Corral R, Moss J, Slugocki TS, Singh EK, Davis MR, Ravula S, Spicer JE, Oelrich JL, Thornquist A, Pan CM, et al. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Bioorganic & Medicinal Chemistry. 18: 6822-56. PMID 20708938 DOI: 10.1016/J.Bmc.2010.07.042 |
0.529 |
|
2008 |
Singh EK, Ravula S, Pan CM, Pan PS, Vasko RC, Lapera SA, Weerasinghe SV, Pflum MK, McAlpine SR. Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold. Bioorganic & Medicinal Chemistry Letters. 18: 2549-54. PMID 18381239 DOI: 10.1016/J.Bmcl.2008.03.047 |
0.624 |
|
2007 |
Rodriguez RA, Pan PS, Pan CM, Ravula S, Lapera S, Singh EK, Styers TJ, Brown JD, Cajica J, Parry E, Otrubova K, McAlpine SR. Synthesis of second-generation sansalvamide A derivatives: novel templates as potential antitumor agents. The Journal of Organic Chemistry. 72: 1980-2002. PMID 17315929 DOI: 10.1021/Jo061830J |
0.537 |
|
Show low-probability matches. |